A Phase Ib/II Study to Investigate the Safety of SHR-1819 in Children and Adolescents With Moderate-to-severe Atopic Dermatitis
Clinical trial NCT06713499 · COMPLETED
Trial details
- NCT number
- NCT06713499
- Sponsor
- Guangdong Hengrui Pharmaceutical Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-18
- Primary completion
- 2025-11-22
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.